University of California San Francisco

Shant Vartanian
Shant
Vartanian
MD

Staff Physician

Academic Office:
400 Parnassus Ave, A581, Box 0222
San Francisco, CA 94143
Tel: 415-353-4366
Email: [email protected]
Asst: [email protected]

Biography

Dr. Vartanian is dedicated clinician and researcher specializing in the intersection of diabetes, end-stage renal disease, and peripheral arterial disease, with a particular focus on emerging technologies. An experienced clinical investigator, he has served as a principal investigator in numerous clinical trials within this field, aiming to integrate innovative solutions to improve patient outcomes. By exploring the complex interplay between metabolic disorders and vascular health, Dr. Vartanian emphasizes the development and application of cutting-edge technologies that works to bridge the gap between research and clinical practice, particularly those that significantly impact patient quality of life.

Education

Institution Degree Dept or School End Date
University of California, San Francisco Fellow, Vascular Surgery 2012
University of California, San Francisco Vascular Surgery Fellowship School of Medicine 2012
University of Calfornia, San Francisco General Surgery Residency School of Medicine 2010
University of California, San Francisco Chief Resident, General Surgery 2010
University of California, San Francisco Resident, General Surgery 2009
University of California, San Francisco Post-Doctoral Research Fellow, Laboratory for Acce 2007
University of California, San Francisco Intern, General Surgery 2004
St. Louis University M.D. School of Medicine 2003

Board Certifications

  • American Board of Surgery, 2011

Clinical Expertise

Aortic Dissection

Abdominal Aortic Aneurysm

Carotid Artery Disease

Complex Limb Revascularization

Critical Limb Ischemia

Diabetic Vascular Disease

Dialysis Access

Endovascular Aneurysm Repair

Mesenteric Artery Disease

Peripheral Artery Disease

Thoracic Aortic Aneurysm

Thoracic Outlet Syndrome

Clinical Trials

  1. Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2 (NCT04514861)
    Related Conditions: Peripheral Artery Disease| Start Date: | End Date:

In the News

Surgical Innovations Accelerator Projects Harness Unique Talents of MTM Student Teams
October, 05, 2017 | UCSF Surgical Innovations Program
Accelerator Awards Presented at 2nd Annual Surgical Innovations Shark Tank
April, 24, 2017 | UCSF Surgical Innovations Program

Research Narrative

Dr. Vartanian is interested in comparing the effectiveness of endovascular treatments for peripheral arterial disease. By understanding the safety, effectiveness, and cost of each intervention, the aim of the research is to assist patients and clinicians in making informed decisions about treatment options.

Research Interests

  • Comparative effectiveness of endovacular interventions for lower extremity arterial disease
  • Endovascular interventions for acute and chronic aortic conditions

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 44
  1. Long Term Results of a Comparative Study of Percutaneous and Surgically Created Proximal Forearm Arteriovenous Fistulae.
    Shahverdyan R, Mehta TI, Inston N, Konner K, Vartanian S| | PubMed
  2. Vein distensibility is superior to vein diameter for predicting unassisted maturation of arteriovenous fistulae.
    Woodford C, Zarkowsky D, Wu B, Oskowitz AZ, Shahverdyan R, Vartanian SM| | PubMed
  3. Relevance of BEST-CLI trial endpoints in a tertiary care limb preservation program.
    Liu IH, El Khoury R, Hiramoto JS, Gasper WJ, Schneider PA, Vartanian SM, Conte MS| | PubMed
  4. Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers.
    Moyer J, Wilson MW, Sorrentino TA, Santandreu A, Chen C, Hu D, Kerdok A, Porock E, Wright N, Ly J, Blaha C, Frassetto LA, Fissell WH, Vartanian SM, Roy S| | PubMed
  5. Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.
    Kim EJ, Chen C, Gologorsky R, Santandreu A, Torres A, Wright N, Goodin MS, Moyer J, Chui BW, Blaha C, Brakeman P, Vartanian S, Tang Q, David Humes H, Fissell WH, Roy S| | PubMed
  6. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.
    Lopez JL, Ramirez JL, Phu TA, Duong P, Bouchareychas L, Kuhrau CR, Lin PY, Eckalbar WL, Barczak AJ, Rudolph JD, Maliskova L, Conte MS, Vartanian SM, Raffai RL, Oskowitz AZ| | PubMed
  7. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, El Khoury R, Wu B, Gasper WJ, Schneider PA, Hiramoto JS, Vartanian SM, Conte MS| | PubMed
  8. Characterization of human islet function in a convection-driven intravascular bioartificial pancreas.
    Santandreu AG, Taheri-Tehrani P, Feinberg B, Torres A, Blaha C, Shaheen R, Moyer J, Wright N, Szot GL, Fissell WH, Vartanian S, Posselt A, Roy S| | PubMed
  9. Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, Wu B, Krepkiy V, El Khoury R, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM| | PubMed
  10. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    El Khoury R, Wu B, Kupiec-Weglinski SA, Liu IH, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS| | PubMed
44
View all 44 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 44
  1. Long Term Results of a Comparative Study of Percutaneous and Surgically Created Proximal Forearm Arteriovenous Fistulae.
    Shahverdyan R, Mehta TI, Inston N, Konner K, Vartanian S| | PubMed
  2. Vein distensibility is superior to vein diameter for predicting unassisted maturation of arteriovenous fistulae.
    Woodford C, Zarkowsky D, Wu B, Oskowitz AZ, Shahverdyan R, Vartanian SM| | PubMed
  3. Relevance of BEST-CLI trial endpoints in a tertiary care limb preservation program.
    Liu IH, El Khoury R, Hiramoto JS, Gasper WJ, Schneider PA, Vartanian SM, Conte MS| | PubMed
  4. Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers.
    Moyer J, Wilson MW, Sorrentino TA, Santandreu A, Chen C, Hu D, Kerdok A, Porock E, Wright N, Ly J, Blaha C, Frassetto LA, Fissell WH, Vartanian SM, Roy S| | PubMed
  5. Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.
    Kim EJ, Chen C, Gologorsky R, Santandreu A, Torres A, Wright N, Goodin MS, Moyer J, Chui BW, Blaha C, Brakeman P, Vartanian S, Tang Q, David Humes H, Fissell WH, Roy S| | PubMed
  6. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.
    Lopez JL, Ramirez JL, Phu TA, Duong P, Bouchareychas L, Kuhrau CR, Lin PY, Eckalbar WL, Barczak AJ, Rudolph JD, Maliskova L, Conte MS, Vartanian SM, Raffai RL, Oskowitz AZ| | PubMed
  7. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, El Khoury R, Wu B, Gasper WJ, Schneider PA, Hiramoto JS, Vartanian SM, Conte MS| | PubMed
  8. Characterization of human islet function in a convection-driven intravascular bioartificial pancreas.
    Santandreu AG, Taheri-Tehrani P, Feinberg B, Torres A, Blaha C, Shaheen R, Moyer J, Wright N, Szot GL, Fissell WH, Vartanian S, Posselt A, Roy S| | PubMed
  9. Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, Wu B, Krepkiy V, El Khoury R, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM| | PubMed
  10. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    El Khoury R, Wu B, Kupiec-Weglinski SA, Liu IH, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS| | PubMed
  11. Applicability of the Vascular Quality Initiative mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population.
    El Khoury R, Wu B, Kupiec-Weglinski SA, Dang LE, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Simons JP, Conte MS| | PubMed
  12. Toward endovascular treatment of type A aortic dissection with smaller landing zones and more patient eligibility.
    Wisneski AD, Kumar V, Vartanian SM, Oskowitz AZ| | PubMed
  13. Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia.
    Liu IH, Wu B, Krepkiy V, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM| | PubMed
  14. Transvenous Type 2 Endoleak Embolization Using Intravascular Ultrasound Guidance via a Left-Sided Inferior Vena Cava.
    Hicks RM, Vartanian SM, Lehrman ED| | PubMed
  15. Contemporary Experience with Paravisceral Aortic Aneurysm (PVAAA) Repair in a Tertiary Center.
    Zarkowsky DS, Inman JT, Sorrentino TA, Hiramoto JS, Vartanian SM, Eichler CM, Reilly LM, Gasper WJ, Conte MS| | PubMed
  16. Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas.
    Shahverdyan R, Beathard G, Mushtaq N, Litchfield TF, Vartanian S, Konner K, Jennings WC| | PubMed
  17. The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.
    El Khoury R, Wu B, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS| | PubMed
  18. Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program.
    Lancaster EM, Wu B, Iannuzzi J, Oskowitz A, Gasper W, Vartanian S, Wick E, Hiramoto J, Eichler C, Lobo E, Reyzelman A, Reilly L, Sosa JA, Conte MS| | PubMed
  19. Natural history of acute pediatric iliofemoral artery thrombosis treated with anticoagulation.
    Ramirez JL, Kuhrau CR, Wu B, Zarkowsky DS, Conte MS, Oskowitz AZ, Nijagal A, Vartanian SM| | PubMed
  20. Antegrade common femoral artery closure device use is associated with decreased complications.
    Ramirez JL, Zarkowsky DS, Sorrentino TA, Hicks CW, Vartanian SM, Gasper WJ, Conte MS, Iannuzzi JC| | PubMed
  21. Functional outcomes of arteriovenous fistulas recruited with regional anesthesia.
    Zarkowsky DS, Wu B, Gray AT, Oskowitz AZ, Vartanian SM| | PubMed
  22. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women.
    Cedarbaum E, Ma Y, Scherzer R, Price JC, Adimora AA, Bamman M, Cohen M, Fischl MA, Matsushita K, Ofotokun I, Plankey M, Seaberg EC, Yin MT, Grunfeld C, Vartanian S, Sharma A, Tien PC| | PubMed
  23. Congenital superior mesenteric artery aneurysm in a 6-week-old infant presenting with upper gastrointestinal bleeding.
    Subbaraj L, Beleniski F, Courtier J, Vartanian S, Nijagal A| | PubMed
  24. In vitro and in vivo hemocompatibility assessment of ultrathin sulfobetaine polymer coatings for silicon-based implants.
    Iqbal Z, Kim S, Moyer J, Moses W, Abada E, Wright N, Kim EJ, Park J, Fissell WH, Vartanian S, Roy S| | PubMed
  25. The impact of prior aortic surgery on outcomes after multibranched endovascular aortic aneurysm repair.
    Kaushik S, Gasper WJ, Ramanan B, Vartanian SM, Reilly LM, Chuter TAM, Hiramoto JS| | PubMed
  26. A mixed-methods investigation of incident Hemodialysis access in a safety-net population.
    Rich NC, Vartanian SM, Sharief S, Freitas DJ, Tuot DS| | PubMed
  27. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program.
    Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Reyzelman AM, Hiramoto JS, Conte MS| | PubMed
  28. Correction: An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport.
    Song S, Blaha C, Moses W, Park J, Wright N, Groszek J, Fissell W, Vartanian S, Posselt AM, Roy S| | PubMed
  29. An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport.
    Song S, Blaha C, Moses W, Park J, Wright N, Groszek J, Fissell W, Vartanian S, Posselt AM, Roy S| | PubMed
  30. Lower extremity weakness is associated with elevated blood and cerebrospinal fluid glucose levels following multibranched endovascular aortic aneurysm repair.
    Hiramoto JS, Fernandez C, Gasper W, Vartanian S, Reilly L, Chuter T| | PubMed
  31. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program.
    Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS| | PubMed
  32. Low-profile versus standard-profile multibranched thoracoabdominal aortic stent grafts.
    Ramanan B, Fernandez CC, Sobel JD, Gasper WJ, Vartanian SM, Reilly LM, Chuter TA, Hiramoto JS| | PubMed
  33. Standard off-the-shelf versus custom-made multibranched thoracoabdominal aortic stent grafts.
    Fernandez CC, Sobel JD, Gasper WJ, Vartanian SM, Reilly LM, Chuter TA, Hiramoto JS| | PubMed
  34. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease.
    Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J| | PubMed
  35. Surgical intervention for peripheral arterial disease.
    Vartanian SM, Conte MS| | PubMed
  36. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service.
    Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS| | PubMed
  37. Lower extremity weakness after endovascular aneurysm repair with multibranched thoracoabdominal stent grafts.
    Sobel JD, Vartanian SM, Gasper WJ, Hiramoto JS, Chuter TA, Reilly LM| | PubMed
  38. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease.
    Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS| | PubMed
  39. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
    Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS| | PubMed
  40. Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice.
    Murphy PA, Lam MT, Wu X, Kim TN, Vartanian SM, Bollen AW, Carlson TR, Wang RA| | PubMed
  41. Therapeutic angiogenesis.
    Vartanian SM, Sarkar R| | PubMed
  42. Oklahoma prosthesis: resection of tumor of clavicle and chest wall reconstructed with a custom composite graft.
    Vartanian SM, Colaco S, Orloff LE, Theodore PR| | PubMed
  43. Ischemic colitis: spectrum of disease and outcome.
    Scharff JR, Longo WE, Vartanian SM, Jacobs DL, Bahadursingh AN, Kaminski DL| | PubMed
  44. Laparoscopic hernioplasty: significant complications.
    Felix EL, Harbertson N, Vartanian S| | PubMed